Multi Commodity Exchange of India Ltd Reports Nearly 100% Increase in Total Income for H1 FY27 with ₹1,603 Crore
Profit after tax rises to ₹868 crore; futures average daily turnover hits ₹61,280 crore reflecting strong market activity
Multi Commodity Exchange of India Ltd (MCX) reported strong financial growth for the half year ended September 30, 2026 (H1 FY27), with total income reaching ₹1,603 crore, nearly doubling the previous year's ₹807 crore. Profit after tax rose to ₹868 crore, while futures and options average daily turnover surged significantly, reflecting robust trading activity in bullion, energy, and base metals segments.
Multi Commodity Exchange of India Ltd
Investor Presentation
Multi Commodity Exchange of India Ltd (MCX) reported total income of ₹1,603 crore for the half year ended September 30, 2026, nearly doubling the ₹807 crore recorded in the same period last year. Profit after tax reached ₹868 crore, showcasing substantial financial growth.
MCX's operating revenue for H1 FY27 was ₹1,502 crore, more than double the ₹748 crore in H1 FY26. The company’s EBITDA margin improved to 75.2% compared to 67.5% the previous year, resulting in an EBITDA of ₹1,206 crore.
Futures average daily turnover (ADT) grew 49.2% year-on-year to ₹61,280 crore, while options ADT notional value surged 242.4% to ₹10,96,529 crore. Segment-wise, bullion futures ADT increased by 32.2% year-on-year to ₹42,705 crore, and energy futures ADT more than doubled to ₹14,530 crore.
Deliverable metal contracts recorded cumulative deliveries of over 6.21 lakh tonnes since becoming compulsory delivery contracts. The exchange reported continued dominance with over 98% market share in futures and options turnover.
Client participation was strong with approximately 4.0 lakh futures clients and 13.0 lakh options clients trading in Q2 FY27, supported by 613 members and presence in 652 cities or towns.
Highlights
- Total income for H1 FY27: ₹1,603 crore, up 98.6% YoY vs ₹807 crore in H1 FY26
- Profit after tax: ₹868 crore, up 116.4% YoY vs ₹401 crore in H1 FY26
- Operating revenue: ₹1,502 crore, up 100.8% YoY
- Futures average daily turnover: ₹61,280 crore, up 49.2% YoY
- Options average daily turnover (notional): ₹10,96,529 crore, up 242.4% YoY
- EBITDA margin improved to 75.2% from 67.5% YoY, EBITDA ₹1,206 crore for H1 FY27
Key Data Snapshot
Financial performance
- MCX achieved total income of ₹1,603 crore in H1 FY27, up nearly 99% year-on-year from ₹807 crore in H1 FY26.
- Profit after tax more than doubled to ₹868 crore from ₹401 crore in the previous year period.
- Operating revenue rose 100.8% YoY to ₹1,502 crore.
- EBITDA margin rose to 75.2% compared to 67.5% in H1 FY26, with EBITDA at ₹1,206 crore.
Operational performance
- Futures average daily turnover for H1 FY27 was ₹61,280 crore, increasing 49.2% over H1 FY26.
- Options ADT (notional premium) surged 242.4% to ₹10,96,529 crore from ₹3,20,255 crore year-on-year.
- Bullion futures ADT increased 32.2% year-on-year to ₹42,705 crore in Q2 FY27.
- Deliverable metal contracts saw cumulative deliveries of over 6.21 lakh tonnes since becoming compulsory delivery contracts.
Background and context
- MCX is India's leading commodity derivatives exchange with over 98% market share in futures and options turnover.
- The exchange offers trading in bullion, energy, base metals and agriculture commodities among others.
- Strong client participation with 4.0 lakh futures and 13.0 lakh options clients in Q2 FY27.
- MCX has a nationwide presence with 613 members and coverage across 652 cities or towns.
Highlights
- Total income for H1 FY27: ₹1,603 crore, up 98.6% YoY vs ₹807 crore in H1 FY26
- Profit after tax: ₹868 crore, up 116.4% YoY vs ₹401 crore in H1 FY26
- Operating revenue: ₹1,502 crore, up 100.8% YoY
- Futures average daily turnover: ₹61,280 crore, up 49.2% YoY
- Options average daily turnover (notional): ₹10,96,529 crore, up 242.4% YoY
- EBITDA margin improved to 75.2% from 67.5% YoY, EBITDA ₹1,206 crore for H1 FY27
Disclosures
- SEBI regulations governing commodity derivatives trading
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
GlaxoSmithKline India Achieves 21% Revenue Growth in Q2 FY27 with Innovation-Driven Portfolio Expansion
GlaxoSmithKline Pharmaceuticals Limited reported a 21% revenue increase to ₹1180 crore in Q2 FY27, driven by strong sales execution and a rising contribution from its innovation portfolio which grew to 7% of total sales. The company sustained market leadership with a 25% share in its representative market amid competitive industry growth.
Read Full StoryZydus Lifesciences Posts Rs. 79,096 mn Revenue in Q2 FY27 with 29% YoY Growth Bolstered by India Formulations
Zydus Lifesciences Limited recorded a 29% year-on-year increase in revenues to Rs. 79,096 million during the second quarter of fiscal year 2027, driven primarily by robust growth in their India branded formulations and North America markets.
Read Full StoryITC Limited Announces Participation in Major Investor Conferences in November 2026
ITC Limited announced that its representatives will participate in two key investor conferences in November 2026, including the 29th CITIC CLSA India Forum in Mumbai and Morgan Stanley's 25th Annual Asia Pacific Summit in Singapore.
Read Full Story